Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft, H1 2023 Earnings Call, Jul 21, 2023 - Marketscreener.com
SARTF Stock | USD 182.98 9.77 5.07% |
Roughly 62% of Sartorius Aktiengesellscha's investor base is looking to short. The analysis of overall sentiment of trading Sartorius Aktiengesellschaft pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Sartorius Aktiengesellscha's historical and current headlines, can help investors time the market. In addition, many technical investors use Sartorius Aktiengesellscha stock news signals to limit their universe of possible portfolio assets.
Sartorius Aktiengesellscha pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Sartorius daily returns and investor perception about the current price of Sartorius Aktiengesellschaft as well as its diversification or hedging effects on your existing portfolios.
Sartorius |
Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft, H1 2023 Earnings Call, Jul 21, 2023 Marketscreener.com
Read at news.google.com
Sartorius Aktiengesellscha Fundamental Analysis
We analyze Sartorius Aktiengesellscha's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sartorius Aktiengesellscha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sartorius Aktiengesellscha based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Sartorius Aktiengesellscha is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Sartorius Aktiengesellscha Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sartorius Aktiengesellscha pink sheet to make a market-neutral strategy. Peer analysis of Sartorius Aktiengesellscha could also be used in its relative valuation, which is a method of valuing Sartorius Aktiengesellscha by comparing valuation metrics with similar companies.
Peers
Sartorius Aktiengesellscha Related Equities
CZMWF | Carl Zeiss | 5.49 | ||||
STAA | STAAR Surgical | 3.31 | ||||
ICUI | ICU Medical | 1.42 | ||||
WST | West Pharmaceutical | 0.97 | ||||
RGEN | Repligen | 0.89 | ||||
RMD | ResMed | 0.61 | ||||
MMSI | Merit Medical | 0.48 |
Complementary Tools for Sartorius Pink Sheet analysis
When running Sartorius Aktiengesellscha's price analysis, check to measure Sartorius Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Aktiengesellscha is operating at the current time. Most of Sartorius Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Sartorius Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Aktiengesellscha's price. Additionally, you may evaluate how the addition of Sartorius Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |